Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Valneva (NASDAQ:VALN) through any online brokerage.
Other companies in Valneva’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Valneva has a consensus price target of $16.00.
The stock price for Valneva (NASDAQ: VALN) is $6.09 last updated September 25, 2026 at 8:20 AM EDT.
There are no upcoming dividends for Valneva.
Valneva does not have any upcoming earnings scheduled.
There is no upcoming split for Valneva.
Valneva is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.